Norway Savings Bank Novartis Ag Transaction History

Norway Savings Bank

$184 Million
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	SELL	$92.27 - $101.54 $12,456 - $13,707	-135 Reduced 5.91%	2,148 $216,000
Q3 2023 Oct 23, 2023	SELL	$94.73 - $105.13 $16,577 - $18,397	-175 Reduced 7.12%	2,283 $232,000
Q2 2023 Jul 11, 2023	SELL	$92.52 - $104.91 $63,838 - $72,387	-690 Reduced 21.92%	2,458 $248,000
Q1 2023 Apr 11, 2023	SELL	$80.03 - $92.81 $36,013 - $41,764	-450 Reduced 12.51%	3,148 $289,000
Q4 2022 Jan 10, 2023	SELL	$75.55 - $92.52 $19,265 - $23,592	-255 Reduced 6.62%	3,598 $326,000
Q3 2022 Oct 18, 2022	SELL	$74.61 - $87.26 $60,807 - $71,116	-815 Reduced 17.46%	3,853 $293,000
Q2 2022 Jul 15, 2022	SELL	$80.52 - $93.75 $72,870 - $84,843	-905 Reduced 16.24%	4,668 $394,000
Q1 2022 Apr 08, 2022	SELL	$80.11 - $90.62 $32,444 - $36,701	-405 Reduced 6.77%	5,573 $489,000
Q4 2021 Jan 18, 2022	SELL	$79.7 - $88.13 $204,430 - $226,053	-2,565 Reduced 30.02%	5,978 $523,000
Q3 2021 Oct 14, 2021	SELL	$81.78 - $95.14 $121,852 - $141,758	-1,490 Reduced 14.85%	8,543 $699,000
Q2 2021 Jul 15, 2021	SELL	$85.24 - $94.15 $188,806 - $208,542	-2,215 Reduced 18.08%	10,033 $915,000
Q1 2021 Apr 13, 2021	SELL	$83.5 - $98.47 $10,437 - $12,308	-125 Reduced 1.01%	12,248 $1.05 Million
Q4 2020 Jan 13, 2021	SELL	$78.07 - $94.43 $5,464 - $6,610	-70 Reduced 0.56%	12,373 $1.17 Million
Q3 2020 Oct 14, 2020	SELL	$82.14 - $91.0 $12,731 - $14,105	-155 Reduced 1.23%	12,443 $1.08 Million
Q2 2020 Jul 07, 2020	BUY	$80.93 - $91.1 $9,306 - $10,476	115 Added 0.92%	12,598 $1.1 Million
Q1 2020 Apr 14, 2020	BUY	$70.67 - $99.01 $706 - $990	10 Added 0.08%	12,483 $1.03 Million
Q4 2019 Jan 16, 2020	SELL	$84.35 - $95.37 $8,435 - $9,537	-100 Reduced 0.8%	12,473 $1.18 Million
Q3 2019 Oct 22, 2019	BUY	$85.54 - $94.26 $11,120 - $12,253	130 Added 1.04%	12,573 $1.09 Million
Q2 2019 Jul 11, 2019	BUY	$75.4 - $92.8 $31,291 - $38,512	415 Added 3.45%	12,443 $1.14 Million
Q1 2019 Apr 12, 2019	BUY	$75.32 - $86.15 $39,919 - $45,659	530 Added 4.61%	12,028 $1.16 Million
Q4 2018 Jan 16, 2019	SELL	$73.66 - $82.02 $18,046 - $20,094	-245 Reduced 2.09%	11,498 $986,000
Q3 2018 Oct 16, 2018	SELL	$66.94 - $77.43 $71,358 - $82,540	-1,066 Reduced 8.32%	11,743 $1.01 Million
Q2 2018 Jul 12, 2018	BUY	$64.91 - $73.36 $23,367 - $26,409	360 Added 2.89%	12,809 $968,000
Q1 2018 Apr 10, 2018	SELL	$70.39 - $84.15 $38,432 - $45,945	-546 Reduced 4.2%	12,449 $1.01 Million
Q4 2017 Jan 16, 2018	SELL	$72.33 - $77.64 $20,614 - $22,127	-285 Reduced 2.15%	12,995 $1.09 Million
Q3 2017 Oct 20, 2017	BUY	$74.14 - $77.27 $984,579 - $1.03 Million	13,280	13,280 $1.14 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norway Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norway Savings Bank with notifications on news.

Account